Preoperative Hypocalcaemia, a Comparative Clinical Trial (professor)

December 25, 2019 updated by: Hazem Nour Abdellatif, Zagazig University

Vitamin D and Calcium Supplementation to Prevent Post-total Thyroidectomy Hypocalcaemia, a Comparative Clinical Trial

two groups of patients undergoing total thyroidectomy one group received calcium and vit d prophylaxis the other group received no prophylaxis the investigator measured calcium level post and preoperative and development of tetant was recorded

Study Overview

Detailed Description

This study is randomized controlled trial carried out on 86 patients undergoing total thyroidectomy in the period between January 2018 and November 2019. Patients were randomly allocated into two groups each one 43 patients the first group is the supplementation group where patients received oral vitamin D 40000 IU and calcium tablets 1 g once before surgery.

Patient included in this study are those above 18 years old undergoing total thyroidectomy.

Patients excluded from this study are those with

  • Previous thyroid surgery
  • Malabsorption diseases
  • Pregnancy
  • Previous parathyroid disease or surgery
  • Vitamin D deficiency
  • Renal impairment
  • Hypo or hyper calcaemia
  • ASA class 3,4

all patients in this study were subjected to thorough history taking full clinical examination, body mass index calculation, proper assessment of the original thyroid disease requiring surgery, preoperative investigations done as usual in addition to serum calcium, serum magnesium, serum vitamin D and serum parathormon level.

Serum calcium and serum parathormon were tested after 6, 12 and 48 postoperative hours, patients were discharged on the third postoperative day except if further hospitalization was indicated, after discharge patients were followed up in the outpatient clinic by one of the surgical team, serum calcium and parathormon level were tested after1 months, 3 months and after 6th months.

The primary outcome of this study is the development of hypocalcaemia either clinically or laboratory.

Clinical hypocalcaemia means development of perioral and \ or acral tingling and numbness, twitches of the perioral region on tapping in front of the ear" Chvostec's sign'', muscle twitches and development of carpopedal spasm.

Laboratory hypocalcaemia means serum calcium level below 8.5 mg\dl. Secondary outcome is the postoperative parathormon level. Preoperative data, postoperative clinical follow up and laboratory data were collected and analyzed using SPSS 22 program package.

Principles of total thyroidectomy; Total thyroidectomy was performed under general anesthesia, through lower neck collar incision, skin and platysma muscle flap was raised till the thyroid cartilage, opening the midline raphe, exploration of each thyroid lobe and tracing the inferior thyroid artery while emerging from underneath the carotid artery, the inferior thyroid artery was identified with its branches supplying the parathyroid gland, which was identified and preserved with its blood supply, the recurrent laryngeal nerve was searched for in the triangle between the carotid artery , trachea and the inferior thyroid artery. The external laryngeal nerve was identified and preserved 1 cm superior to the upper thyroid pole. If radical thyroidectomy was deemed the same principles of preserving parathyroid glands and their blood supply, recurrent and external laryngeal nerves. If the surgeons ere sure of damaging or removing the parathyroid glands a half of one of them was minced and transplanted in the subcutaneous tissue of the left forearm

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sharqya
      • Zagazig, Sharqya, Egypt, 44519
        • Zagazig Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

• patient undergoing total thyroidectomy

Exclusion Criteria:

  • Previous thyroid surgery
  • Malabsorption diseases
  • Pregnancy
  • Previous parathyroid disease or surgery
  • Vitamin D deficiency
  • Renal impairment
  • Hypo or hyper calcaemia
  • ASA class 3,4

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: supplementation arm
43 patients undergoing total thyroidectomy received 40000 IU vit D and once before operation and 500mg calcium tab 4 times in the day before surgery
comparison between pre- and postoperative calcium and vitamin d level after vit d and calcium supplementation
Other Names:
  • calcium supplementation
Active Comparator: non-supplementation arm
43 patients undergoing total thyroidectomy received rice starch tablets /6 hrs in the day before surgery
rice starch tablets as placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of participants with hypocalcemia
Time Frame: 24 hrs post operative
calcium level below 8.5 mg\dl measured by serum calcium assay
24 hrs post operative
number of participants with hypocalcaemia
Time Frame: after 7 days post operative
calcium level below 8.5 mg\dl measured by serum calcium assay
after 7 days post operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of participants with decreased parathormone level below normal level
Time Frame: ( 1st month post operative)
level of parathormone below 10 pg/mL
( 1st month post operative)
number of participants with tetany
Time Frame: 1 week
development of tingling, numbness or carpopedal spasm measured by clinical examination and patient history
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: hazem nour, zag university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

December 15, 2019

Study Completion (Actual)

December 15, 2019

Study Registration Dates

First Submitted

December 22, 2019

First Submitted That Met QC Criteria

December 25, 2019

First Posted (Actual)

December 27, 2019

Study Record Updates

Last Update Posted (Actual)

December 27, 2019

Last Update Submitted That Met QC Criteria

December 25, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Thyroidectomy

Clinical Trials on Vitamin D

3
Subscribe